BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17237004)

  • 21. Diffuse aggressive lymphoma.
    Fisher RI; Miller TP; O'Connor OA
    Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemotherapy: the new standard in aggressive non-Hodgkin's lymphoma in the elderly.
    Coiffier B
    Semin Oncol; 2003 Feb; 30(1 Suppl 2):21-7. PubMed ID: 12652461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab.
    Boye J; Elter T; Engert A
    Ann Oncol; 2003 Apr; 14(4):520-35. PubMed ID: 12649096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
    Hernandez MC; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1274-87. PubMed ID: 15275710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunochemotherapy in indolent non-Hodgkin's lymphoma.
    Czuczman MS
    Semin Oncol; 2002 Apr; 29(2 Suppl 6):11-7. PubMed ID: 12040529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
    Fanale MA; Younes A
    Drugs; 2007; 67(3):333-50. PubMed ID: 17335294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective.
    Sehn LH; Connors JM
    Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):26-34. PubMed ID: 15934515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.
    Czuczman MS; Fallon A; Mohr A; Stewart C; Bernstein ZP; McCarthy P; Skipper M; Brown K; Miller K; Wentling D; Klippenstein D; Loud P; Rock MK; Benyunes M; Grillo-López AJ; Bernstein SH
    Semin Oncol; 2002 Feb; 29(1 Suppl 2):36-40. PubMed ID: 11842387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A decade of rituximab: improving survival outcomes in non-Hodgkin's lymphoma.
    Molina A
    Annu Rev Med; 2008; 59():237-50. PubMed ID: 18186705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab for the treatment of diffuse large B-cell lymphomas.
    Held G; Pöschel V; Pfreundschuh M
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1175-86. PubMed ID: 16925484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of non-Hodgkin's lymphoma: a look over the past decade.
    Coiffier B
    Clin Lymphoma Myeloma; 2006 Oct; 7 Suppl 1():S7-13. PubMed ID: 17101073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review.
    Vettori S; Staibano S; Mascolo M; Ilardi G; Valentini G
    Clin Rheumatol; 2010 Jan; 29(1):1-6. PubMed ID: 19809778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New treatment strategies for aggressive lymphoma.
    Younes A
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):10-3. PubMed ID: 15726533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of mitoxantrone in non-Hodgkin's lymphoma.
    Armitage JO
    Oncology (Williston Park); 2002 Apr; 16(4):490-502, 507-8; discussion 511-2, 514. PubMed ID: 12017536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment paradigms in aggressive non-Hodgkin's lymphoma in elderly patients.
    Coiffier B
    Clin Lymphoma; 2002 Dec; 3 Suppl 1():S12-8. PubMed ID: 12521384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of diffuse large B-cell lymphoma: a risk-based approach.
    Sehn LH; Connors JM
    Clin Lymphoma Myeloma; 2006 Oct; 7 Suppl 1():S14-9. PubMed ID: 17101068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic strategies for aggressive lymphomas: the trials of the DSHNHL.
    Schmits R; Glass B; Trümper L; Pfreundschuh M;
    Ann Hematol; 2001; 80 Suppl 3():B77-83. PubMed ID: 11757714
    [No Abstract]   [Full Text] [Related]  

  • 38. [Malignant lymphoma, multiple myeloma and myeloproliferative diseases in the elderly].
    Umeda M
    Nihon Ronen Igakkai Zasshi; 2004 Nov; 41(6):594-7. PubMed ID: 15651367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma.
    Scott SD
    Cancer Pract; 1998; 6(3):195-7. PubMed ID: 9652253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphoma.
    Knapp CM; Whitehead KA
    Expert Opin Drug Deliv; 2014 Dec; 11(12):1923-37. PubMed ID: 25244254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.